期刊文献+

脂肪细胞因子chemerin与动脉粥样硬化性脑梗死的关系研究 被引量:8

The correlation research between adipocytokines chemerin and atherosclerosis cerebral infarction
下载PDF
导出
摘要 目的探讨血浆脂肪细胞因子chemerin水平与动脉粥样硬化性脑梗死的关系。方法随机选取我院2012年6月~2013年6月脑梗死急性期患者154例,根据斑块的回声特征分为无斑块组(A1组)52例、稳定型斑块组(A2组)54例和不稳定型斑块组(A3组)48例。另选检查无动脉粥样硬化性脑梗死的健康者50例为对照组(B组)。酶联免疫吸附试验(ELISA)测定各组血浆chemerin水平,分析血浆chemerin与动脉粥样硬化性脑梗死的关系。结果 (1)无斑块组(A1组)、稳定型斑块组(A2组)血浆Chemerin水平与对照组(B组)无显著性差异(P〉0.05);不稳定型斑块组(A3组)血浆Chemerin水平与对照组(B组)差别有统计学意义(P〈0.05);(2)血浆脂肪细胞因子Chemerin是不稳定型动脉粥样硬化性脑梗死的危险因子(OR〉1)。结论脂肪细胞因子Chemerin是不稳定型动脉粥样硬化性脑梗死的危险因素。 Objective To investigate the correlation between the levels of adipocytokines chemerin and cartiod ath- erosclerosis. Methods 154 patients who have had been in our hospital for the treatment of acute cerebral infarction be- tween Jun 2012 and Jun 2013 are were randomly selected to participate in this study. According to the echo features of ath- erosclerotic plaque, all the patients are were divided into 3 groups:no plaque group (group A1 , with 52 cases) ,stable plaque group( group A2 ,with 54 cases) and unstable plaque group( group A3 ,with 48 cases). 50 healthy controls with no cerebro- vascular disease were enrolled in this study as the control group( group B). The serum chemerin levels of all groups of indi- vidals were determined by ELISA to analysis the relationship between the levels of chemerin and cartiod atherosclerosis. Results ( 1 ) The diffrences of the levels of chemerin between no plaque group ( group A1 ) and the control group( group B) made no sence(P 〉 0.05 ). So do that between stable plaque group (group Az ) and the control group (group B)( P 〉 0.05). Neverthless, chemerin' s levels in unstable plaque group( group A3 ) were sensiblely higher than that of the control group ( group B ) ( P 〈 0.05 ). ( 2 ) Chemerin was a risk factor to unstable atherosclerotic cerebral infarction ( OR 〉 1 ). Con- clusion Chemerin was a risk factor to unstable atherosclerotic cerebral infarction.
作者 向君
出处 《中风与神经疾病杂志》 CAS 北大核心 2015年第5期438-440,共3页 Journal of Apoplexy and Nervous Diseases
关键词 脂肪细胞因子 CHEMERIN 脑梗死 动脉粥样硬化 Adipocytokines Chemerin Cerebral infarction Atherosclerosis
  • 相关文献

参考文献2

二级参考文献24

  • 1Nagpal S, Patel S, Jacobe H, et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin[J]. J Invest Dernatol, 1997, 109(1 ) :91-95.
  • 2Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids [J ]. J Exp Med, 2003, 198 (7): 977-985.
  • 3Bozaoglu K, Bolton K, MeMillan J, et aI. Chemerin is a novel adipokine associated with obesity and metabolic syndrome [J]. Endocrinology, 2007, 148(10):4687-4694.
  • 4Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin: a novel adipokine that regulates adipogenesis and adipocyte metabolism [J]. J Biol Chem, 2007, 282(38):28175-28188.
  • 5Du XY, Zabel BA, Myles T, et al. Regulation of chemerin bioactivity by plasma earboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor) ,and platelets [J]. J Biol Chem, 2009, 284 ( 2):751-758.
  • 6Wittamer V, Gregoire F, Robberecht P, et al. The C-terminal non- apeptide of mature chemerin activates the chemerin receptor with low nanomolar potency [ J ]. J Biol Chem, 2004, 279 ( 11 ): 9956-9962.
  • 7Zabel BA, Allen SJ, Kulig P, et al. Chemerin activation by serine proteases of the coagulation,fibrinolytic, and inflammatory cascades [J ]. J Biol Chem, 2005,280 (41 ):34661-34666.
  • 8Wittamer V, Bondue B, Guillabert A, et al. Neutrophilmedisted maturation of chemerin: a link between innate and adaptive immunity [J] . J Immunol, 2005, 175 ( 1 ) :487-493.
  • 9Guillabert A, Wittamer V, Bondue B, et al. Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytie regulation [J]. J Leukocyte Biol, 2008, 84(6):1530-1538.
  • 10Parolini S, Santoro A, Marcenaro E, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues [J ]. Blood, 2007,109 (9):3625-3632.

共引文献13

同被引文献56

  • 1HUANG Q, MA Q F, FENG J, et al. Factors associated with in - hospital delay in intravenous thrombolysis for acute ischemie stroke: Lessons from China[J]. PLoS One,2015,10(11) :143145.
  • 2SWANEPOEL A C, PRETORIUS E. Prevention and follow - up in thromboembolic ischemic stroke : Do we need to think out of the box? [J]. Thromb Res,2015,136(6) :1067 - 1073.
  • 3HAH Y J, KIM N K, KIM M K, et al. Relationship between Chemerin levels and cardiometabolic parameters and degree of coro- nary stenosis in Korean patients with coronary artery disease [ J ]. Diabetes Metab J,2011,35 ( 3 ) :248 - 254.
  • 4LESECHE G, M.SAC J M, HOUBBALAH R, et al. Carotid endarterec- tomy in the acute phase of stroke - in - evolution is safe and effective in selected patients[J]. J Vasc Surg,2012,55(3) :701 -707.
  • 5FERLAND D J, WATTS S W. Chemerin: A comprehensive review elucidating the need for cardiovascular research [ J ]. Pharmacol Res, 2015,99( 11 ) :351 - 361.
  • 6BOZAOGLU K, CURRAN J E, STOCKER C J, et al. Chemerin, a novel adipokine in the regulation of angiogenesis [ J ]. J Clin Endocrinol Metab, 2010,95 (5) :2476 - 2485.
  • 7吴静,卢慧玲,胡秀芬,梁晓燕,林汉华,王宏伟.3T3-L1前脂肪细胞烟碱样胆碱能受体α7亚型功能状态对chemerin及其受体chemerinR基因表达的影响[J].中国动脉硬化杂志,2008,16(6):435-439. 被引量:3
  • 8中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153. 被引量:3406
  • 9中国急性缺血性脑卒中诊治指南2010[J].中国临床医生杂志,2011,39(3):67-73. 被引量:370
  • 10范书英,黎娜,于长安,柯元南,郑金刚,彭文华,陈莉,赵霞,赵桂茹,王丹,王勇.冠心病患者血浆Chemerin水平的变化及其影响因素[J].临床心血管病杂志,2012,28(1):31-33. 被引量:14

引证文献8

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部